CROs in Australia

David Jones
3 days ago
13 min read

CROs in Australia

Australia has established itself as one of the world's most attractive and competitive clinical trial destinations, offering sponsors a compelling combination of a genetically diverse and treatment-naive patient population, highly experienced investigators, a well-developed network of academic medical centers and private research sites, and a favourable operational environment supported by generous R&D tax incentives. With over 27 million inhabitants and a robust universal healthcare system (Medicare) supplemented by a well-resourced private hospital sector, Australia consistently ranks among the top clinical trial markets in the Asia-Pacific region.

The Australian regulatory framework for clinical trials is governed by the Therapeutic Goods Administration (TGA) and overseen by Human Research Ethics Committees (HRECs) registered with the National Health and Medical Research Council (NHMRC). Australia operates a notification-based system through the Clinical Trial Notification (CTN) and Clinical Trial Approval (CTA) schemes, providing sponsors with one of the fastest study start-up timelines globally, often enabling first-patient-in within a matter of weeks. The country's alignment with ICH-GCP standards ensures that data generated in Australia meets the requirements of major regulatory authorities worldwide, including the FDA and EMA, while its R&D tax incentive scheme offers eligible sponsors a rebate of up to 43.5% on qualifying clinical trial expenditure.

The Australian CRO landscape has grown significantly over the past two decades, reflecting the country's increasing importance in global clinical development. It encompasses a wide spectrum of organizations, from global full-service CROs with major Australian operational hubs to regional and local CROs with deep expertise in navigating TGA notifications, HREC and site governance processes, and Medicare-linked research site contracting. Many CROs operating in Australia also serve as regional anchors for broader Asia-Pacific trial operations, making the country a strategic gateway to the wider APAC market.

COG: CRO Summit brings together International leaders from Contract Research Organizations and functional service providers in the Raleigh-Durham Research Triangle to advance operational excellence and innovation in clinical trial delivery.

This premier two-day gathering delivers actionable insights on emerging technologies, strategic collaboration, and the evolving landscape of the global CRO industry.

Find Our More Here: https://www.thepbcgroup.com/crosummit

Here you can find a selection of emerging, mid-size, and large CROs conducting and managing Phase I–IV clinical trials in Australia, each bringing unique expertise in navigating the country's healthcare systems and regulatory requirements.

Novotech

Novotech is an Australia-based CRO providing clinical trial management, site monitoring, data management, biostatistics, and regulatory consulting services, including full drug development consulting from early-stage through to commercialization. They support pharmaceutical and biotech sponsors from early phase product development through to later phase regional and global trials, offering Phase 1 clinical trial units and early-phase CRO services alongside later-phase capabilities across Phase II–IV studies, leveraging their Asia-Pacific in-country relationships, understanding of local regulatory requirements, access to leading investigators, and strong site connections across Australian and broader APAC investigator networks.

Avance Clinical

Avance Clinical is an Australia-headquartered CRO providing clinical trial management, site monitoring, data management, biostatistics, and regulatory consulting services, with an in-house scientific and regulatory affairs team supporting drug development strategy. They support international biotech sponsors from pre-clinical services through Phase 1 and 2 studies, leveraging significant Australian government incentive rebates and rapid start-up regulatory processes, in collaboration with US operations also delivering later-phase CRO services, leveraging their world-class reputation for quality data and ability to secure the maximum rebate on clinical trial spend across Australian and New Zealand investigator networks.

Nucleus Network

Nucleus Network is Australia's leading Phase 1 clinical trial specialist CRO, providing early phase clinical trial management, purpose-built clinical trial units, and site monitoring services. They operate Phase 1 facilities in Melbourne and Brisbane, strategically co-located within leading medical, research and biotech precincts including the Alfred Hospital and Royal Brisbane and Women's Hospital, supporting global pharmaceutical and biotechnology sponsors in conducting first-in-human, biosimilar, and complex early phase studies, leveraging their specialization in first-in-human healthy patient studies and biosimilars and infectious diseases across their Australian clinical network.

Southern Star Research

Southern Star Research is a Sydney-headquartered, full-service CRO providing clinical trial management, medical writing, clinical monitoring, biostatistics, data management, and safety and medical monitoring services. They are early phase specialists (Phase 1 and 2), with particular expertise in designing and managing clinical trials that ensure clients' assets are ready for larger Phase 3 and 4 studies, licensing, partnering and acquisition, supporting biotechnology, pharmaceutical and medical device sponsors, leveraging their local knowledge of the financial, operational and regulatory advantages of conducting clinical trials in Australia across their Australian and Asia-Pacific site networks.

Accelagen

Accelagen is a Melbourne-based CRO providing clinical trial management, medical writing, biostatistics, data management, and regulatory affairs services, alongside medical, safety and pharmacovigilance support. They offer end-to-end services across Regulatory Affairs, Clinical Trials, Biometrics, and Medical, Safety & Pharmacovigilance, plus Strategic Consultation to support clients through all stages of a product's life cycle, supporting pharmaceutical and medical device sponsors with the transition of assets from pre-clinical evaluation stage into human clinical trials, leveraging their local knowledge of Australian regulatory pathways and established site relationships across the country.

iNGENū CRO

iNGENū CRO is a Melbourne-based, physician-led CRO providing clinical trial management, medical writing, biostatistics, data management, pharmacokinetics, and safety and pharmacovigilance services, with an FDA-centric regulatory focus. They are one of Australia's only combined non-clinical and clinical CROs, covering the breadth of services from preclinical drug development through to Phase 1 and Phase 2 clinical trials, supporting biotech sponsors seeking FDA approval, leveraging their model of managing all project management, clinical data, and statistical analysis within Australia, offering sponsors Australian quality control combined with the strategic advantages of APAC sites.

InClin

InClin is a Sydney-based CRO, a regional office of a North American parent company, providing clinical trial management, site monitoring, data management, and regulatory consulting services. Their local services focus on regional clinical operations, including project and vendor management, site management and monitoring, regulatory HREC and TGA submissions, local sponsorship and essential document management, supporting pharmaceutical and biotech sponsors in conducting Phase 1–4 studies across Australian investigator networks, leveraging their local team's country-specific guidance on Australia's well-defined regulatory pathway, accelerated timelines to approval and cost-effectiveness.

GenesisCare Clinical CRO

GenesisCare Clinical CRO (GC CRO) is an Australian-based, full-service oncology-focused CRO providing clinical trial management, project management, medical monitoring, site management, pharmacovigilance, data management, and vendor management services, with a fully integrated dosimetry and imaging core lab. They manage early phase clinical trials in various indications across Australia, New Zealand, USA, China, Europe and South America, supporting pharmaceutical and biotech sponsors in conducting Phase 1–4 studies, leveraging their people's skills across the full spectrum of traditional CRO service offerings, connected through GenesisCare to additional research services and investigator sites across Australian and APAC networks.

Mobius Medical

Mobius Medical is an ISO 9001-certified, Australian-owned boutique CRO providing clinical trial management, electronic data capture (EDC), site feasibility and selection, and regulatory consulting services, with a specialisation in medical devices. They specialise in early phase clinical research for small or start-up companies and overseas clients wishing to include Australia and New Zealand in their global trials, supporting sponsors in conducting Phase I–IV studies from first-in-human through to pivotal approval, leveraging their support navigating TGA, FDA, and ethics committee processes with regulatory strategies tailored to study design, device classification, and regional requirements across their Australian and New Zealand site relationships.

Clinexa

Clinexa is an ISO-certified, full-service CRO with locations in Australia, Singapore and India, providing clinical trial management, site management, data management, and strategic and regulatory consulting services. They offer meaningful solutions from preclinical to regulatory applications, program development, marketing approval and post marketing research, with expertise spanning multiple therapeutic areas, phases of clinical trials, and special areas such as vaccines, biologics and diagnostics, supporting sponsors in conducting Phase I–IV studies across the Asia Pacific region, leveraging their experienced and cohesive regulatory, CMC and toxicology expert team and knowledge of Australia's attractive R&D tax incentive for qualifying sponsors.

Datapharm

Datapharm Australia is Australia's original independent full-service CRO, established in 1987, providing clinical trial management, design, site set-up, monitoring, statistical services, data management, medical writing, and pharmacovigilance and auditing services. They have earned a reputation for quality following involvement in hundreds of clinical trials in over 35 therapeutic areas, spanning Phase I (including first-in-human) to IV, for big pharma, biotech, medical device companies and non-profit organisations, leveraging their relationships with some of the best clinical trial investigators and study sites in Australia and New Zealand and their long-standing knowledge of the local regulatory environment.

CliniRx

CliniRx Australia is the Australian arm of CliniRx, a global full-service CRO providing clinical operations, clinical data management, biostatistics, statistical programming, clinical safety, medical affairs and quality assurance services. They coordinate and manage global Phase 2 to 4 clinical studies through a full-service CRO model integrating all disciplines in support of end-to-end delivery, including planning, protocol development, site selection, monitoring, data management, and regulatory affairs activities, supporting pharma, biotech and medical device sponsors, leveraging their extensive track record across therapeutic areas and experience dealing with the FDA, EMA, DCGI and other national regulatory bodies as part of their broader multinational presence.

Avania

Avania is a global, full-service CRO with an established presence in Australia, providing clinical trial execution and management, strategic consulting, biostatistics, regulatory, and medical writing services, with an exclusive focus on medical devices, IVDs, biologics, and device-drug combination products. Avania supports products from the first-in-human phase through the post-market phase with a customized approach, supporting medical device, MedTech, and diagnostic sponsors, leveraging their strong global presence combined with a deep understanding of local regulatory landscapes across their Australian and broader international network.

Biointelect

Biointelect is a globally recognised Australian consulting and advisory firm offering a unique blend of full-service CRO capabilities and commercialisation consulting. They are a full-service Australian CRO specialising in early-phase and complex clinical trials, integrating clinical trial execution with in-house regulatory and governance expertise, supporting biotech and pharmaceutical sponsors from early research through to market access and health system integration, leveraging their deep local knowledge and regulatory expertise, including Director Services for international clients establishing Australian subsidiaries across the Australian and Asia-Pacific research landscape.

Translational Research Institute

Translational Research Institute (TRI) is a Brisbane-based, multi-partner academic medical research institute providing clinical trial facilities, laboratory and wet lab space, and biopharmaceutical manufacturing infrastructure. Co-located on the Princess Alexandra Hospital campus with two hospitals as major shareholders, TRI operates two clinical trial facilities, one based at the PA Hospital and the other at the Centre for Children's Health Research next to the Queensland Children's Hospital, supporting researchers and biopharmaceutical companies through the translation of laboratory discoveries into patient treatments, leveraging a partnership between QUT, the University of Queensland, Queensland Health and Mater Research, drawing on cross-institutional expertise to rapidly progress research from laboratory discovery to community application.

Australian Healthcare Solutions

Australian Healthcare Solutions (AHS) is a niche medical device Contract Research Organisation based in Australia, providing clinical trial management, field clinical support, and project management services. They offer the full spectrum of Clinical Trial Services and Field Clinical Support services required to seamlessly run medical device clinical trials in Australia and New Zealand, supporting medical device companies at any stage of their commercial journey, leveraging their over 20 years of experience working with medical device technologies, with specific clinical expertise and networks in respiratory, cardiology, cardiac surgery, vascular, thoracics and interventional radiology.

IQVIA

IQVIA is a global CRO with an established Australian presence, providing clinical trial management, site feasibility and identification, biostatistics, regulatory start-up, data management, and project management services. They are the only global CRO in Australia offering fully integrated services for a sponsor's asset, from strategic clinical development planning to clinical trial execution, supporting pharmaceutical and biotech sponsors across all phases of development, leveraging their network of offices in Brisbane, Gold Coast, Sydney, Adelaide, Perth and Melbourne, alongside prime and partner sites, to deliver over 950 clinical trials.

ICON

ICON plc is a global CRO with an established Australian operation based out of Sydney, providing clinical trial management, clinical research associate services, site contracts negotiation, and study start-up services. They provide outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations, spanning all phases of clinical development (Phases I–IV), pre and post-approval, data solutions, and site and patient access services, supporting sponsors conducting trials across the country, leveraging their team based across Sydney, Melbourne, Adelaide, Brisbane and Perth and broader Asia-Pacific regional capability.

PPD

PPD, the clinical research business of Thermo Fisher Scientific, is a global CRO with an established Australia and New Zealand operation, providing clinical trial management, early development support, digital solutions, and laboratory services. They have a team of 450 professionals in Australia and New Zealand, offering robust early development support, advanced digital solutions, and Phase II–IV trial support, with expertise strengths in oncology, hematology, infectious diseases, vaccines, rare diseases, and cutting-edge areas like CGT and GMO studies, supporting pharmaceutical and biotech sponsors, leveraging their well-established local networks and full geographic reach to ensure smooth, top-tier trial execution across the ANZ region.

Parexel

Parexel is one of the largest global CROs, with an established Australian operation based in North Ryde, providing clinical trial management, clinical operations, functional service provider solutions, and regulatory consulting services. They are among the world's largest clinical research organizations, providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster, supporting pharmaceutical and biotech sponsors across multiple therapeutic areas, leveraging their leadership across Clinical Operations in Australia, New Zealand, and Southeast Asia, alongside their Functional Service Provider Team throughout the APAC region.

Fortrea

Fortrea is a leading global CRO with an operational presence across Australia, including teams in Sydney, Melbourne, Adelaide, Perth and Brisbane, providing clinical trial management, site monitoring, clinical research associate services, and data management. They provide pharmaceutical, biotechnology, and medical device customers a wide range of clinical development and technology solutions across more than 20 therapeutic areas, conducting operations in approximately 100 countries, supporting sponsors in full-service and functional service provider models, leveraging their team of more than 19,000 professionals partnering with emerging and large biopharma and medical device and diagnostic companies to support operations and drive healthcare innovation across Australia and the broader Asia-Pacific region.

Syneos Health

Syneos Health is a global, fully integrated biopharmaceutical solutions organization with an established Australian presence, providing clinical trial management, clinical pharmacology, biostatistics, data management and reporting services. Their Clinical Pharmacology services are supported by a global team of more than 150 experienced team members in Australia, Canada, China, Europe, India, the US and Taiwan, providing 24/7 support, with capabilities encompassing medical writing and IRB, biostatistics, pharmacokinetics and pharmacometrics, supporting biotech and pharmaceutical sponsors, with Phase I units in North America, Canada, and Australia supporting complex early development programs with speed, precision, and operational excellence across their integrated global network.

Medpace

Medpace is a scientifically-driven, global, full-service CRO with an established Australian operation based out of Sydney, providing clinical trial management, medical, regulatory and operational services, supported by wholly-owned Central Laboratories, Bioanalytical Lab, and Imaging Core Lab. As a global CRO with an operational footprint across 40 countries, they have broad experience designing and conducting Phase I–IV clinical trials, with Asia Pacific-based medical, operational and regulatory experts who integrate local language, culture, and requirements into study conduct for pharmaceutical, biotechnology and medical device sponsors, leveraging their high-science and disciplined operating approach that embeds medical, regulatory, and operational expertise directly into sponsor trials.

Caidya

Caidya is a global, full-service CRO with Asia-Pacific reach, providing clinical trial management, study start-up, regulatory affairs, biostatistics, and medical writing services. Formed in 2021 from the merger of dMed and Clinipace, they support biopharma innovators through the entire clinical development lifecycle, including pre-IND strategy, clinical operations, regulatory affairs, and post-marketing surveillance, supporting biotech, pharma and medical device sponsors, leveraging their worldwide operational reach combined with deep APAC and China expertise to accelerate global clinical trials across cross-border and regional studies.

Worldwide Clinical Trials

Worldwide Clinical Trials is a full-service global CRO with an Australian office in Melbourne, providing clinical trial management, bioanalytical laboratory services, and post-approval and real-world evidence study services. Their capabilities include bioanalytical laboratory services, Phase I–IV clinical trials, and post-approval and real-world evidence studies, all powered by an accessible team of clinicians, scientists, and researchers who bring first-hand expertise and a collaborative, personalized approach to each clinical program, supporting biotechnology and pharmaceutical sponsors, with a dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases applied across their Australian and broader global network.

PSI CRO

PSI CRO is a leading full-service global CRO with an Australian office in Macquarie Park, Sydney, providing project management, clinical monitoring, regulatory affairs, biostatistics, medical writing, patient recruitment, and site management services. They specialise in predictable patient enrollment across multiple therapeutic areas, offering services for pivotal Phase 2 and 3 clinical trials aimed at providing high-quality, timely, and efficient clinical research solutions, supporting pharmaceutical, biotechnology and medical device sponsors, leveraging their global reach to run clinical trials across multiple continents in 50+ countries, with an emphasis on on-time project delivery across their Australian and broader Asia-Pacific offices.

Premier Research

Premier Research is a global provider of clinical development and consulting services with a long-standing presence in Australia and New Zealand, providing clinical trial management, biostatistics, data management, pharmacovigilance, and quality compliance services. They have expanded their presence in the Asia-Pacific region, increasing activities in Australia and New Zealand, where they have been conducting clinical trials for many years, providing greater access to patients for rare disease studies and other research that relies on hard-to-find patient populations, supporting biotech and specialty pharma sponsors, leveraging their operational and functional experts skilled in novel and adaptive study designs, special population engagement, and strategic risk-based monitoring strategies across their Asia-Pacific network.

Allucent

Allucent is a global, full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies, providing clinical trial management, regulatory strategy consulting, and biostatistical programming services. With over 30 years of background in regulatory trends, therapeutic experience, and operational expertise, they partner with biopharma to advance therapies through every phase of drug development and clinical trials from early-stage to post-approval, supporting sponsors across oncology, neuroscience, cardiometabolic, immunology and inflammation, and infectious diseases, leveraging a range of capabilities equivalent to that of large contract research organizations, combined with the expertise and specialization of niche CROs.

Emerald Clinical

Emerald Clinical (formerly George Clinical) is a globally recognized CRO with a deep Asia-Pacific heritage and dedicated Australian operations, providing clinical trial management, early phase and oncology CRO services, and medical writing. They operate as the CRO of choice in Australia, allowing sponsors to use the same CRO to run their clinical trial programs from early to late phase studies, supporting pharmaceutical, biotechnology and medical device sponsors, leveraging a trusted network of early phase trial sites across Australia, Asia-Pacific, Europe, and North America, with close collaborations with leading Phase I units, hospitals, and research centers to deliver efficient recruitment and trial execution.

Linical

Linical is a global CRO headquartered in Japan with a dedicated Australian subsidiary, providing clinical trial management, regulatory affairs, biometrics, and medical writing services. Linical Australia is the Group's first Southern Hemisphere affiliate, established to provide CRO services and localized expertise for clinical trials conducted in Australia, backed by experienced project teams with knowledge of the Australian clinical and regulatory environment, supporting pharmaceutical and biotechnology sponsors across all phases, leveraging their expectation that sponsors will increasingly conduct Phase 1 trials in Australia before moving to large-scale Phase 2 and 3 trials in Europe and the United States as part of their broader Asia-Pacific network.

Precision for Medicine

Precision for Medicine is a global, biomarker-driven CRO with an established Australian operation, registered in Australia in 2019, providing clinical trial management, monitoring, biostatistics, and regulatory affairs services. They draw on extensive experience through the acquisition of Egan Lee CRO, a company with over 20 years in clinical monitoring and site management, supporting pharmaceutical and biotechnology sponsors, leveraging senior leadership embedded throughout APAC, including a Sydney-based leader with a strong track record of delivering clinical trials across the region, and more than 500 dedicated professionals in the Asia-Pacific to guide oncology and rare disease trials with local expertise and global reach.